Dartdapa 10mg Tablet
Marketer
Addii Biotech Pvt Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Dartdapa 10mg Tablet
Dapagliflozin 10mg tablets are indicated, either independently or as part of a combination therapy, for the management of type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the likelihood of severe diabetic complications and contributing to cardiovascular health protection. Dapagliflozin 10mg tablets may be administered with or without food, consistently at the same time daily, as prescribed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation can elevate blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, as guided by your doctor. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Dehydration is a potential risk; ensure adequate fluid intake. Practicing good hygiene can help minimize the risk of genital fungal infections. Prior to commencing treatment, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before using this medication. Excessive alcohol consumption should be avoided due to a heightened risk of adverse reactions. Regular blood glucose monitoring is crucial throughout treatment.
Primary Ingredients of Dartdapa 10mg Tablet
No text provided to rephrase.
Uses of Dartdapa 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dartdapa 10mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 10mg Dartdapa tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Dartdapa 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dartdapa 10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dartdapa 10mg Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, but consistent timing is recommended.
How Dartdapa 10mg Tablet works:
Glycemic control is achieved with Dartdapa 10mg tablets, an antidiabetic agent that promotes urinary excretion of excess glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dartdapa 10mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dartdapa 10mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid the use of Dartdapa 10mg tablets. Preliminary data in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dartdapa 10mg tablets is likely inadvisable for individuals with kidney disorders and should be omitted. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Ten-milligram Dartdapa tablets are considered safe for use by individuals with hepatic impairment. No alteration of the Dartdapa 10mg Tablet dosage is advised.
What if you forget to take Dartdapa 10mg Tablet :
Should you forget a Dartdapa 10mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dartdapa 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Category | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently